Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Recombinant modified human growth hormone

EU orphan designation number: EU/3/12/1087   
Active ingredient: Recombinant modified human growth hormone
Indication: Treatment of growth hormone deficiency
Sponsor: Richardson Associates Regulatory Affairs Ltd
Tripps Farmhouse, Lower End, Great Milton, Oxfordshire OX44 7NJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/01/2013 Orphan designation EMA/OD/133/12 (2013)476 of 24/01/2013